Skip to main content
SpringerLink
Log in

Eluvia drug-eluting stents for symptomatic PAD may be cost saving in Australia

  • Unknown
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Altaf N, et al. A Budget Impact Model for the use of Drug-Eluting Stents in Patients with Symptomatic Lower-Limb Peripheral Arterial Disease: An Australian Perspective Cardiovascular and Interventional Radiology : 24 Jun 2021. Available from: URL: https://doi.org/10.1007/s00270-021-02848-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eluvia drug-eluting stents for symptomatic PAD may be cost saving in Australia. PharmacoEcon Outcomes News 882, 11 (2021). https://doi.org/10.1007/s40274-021-7845-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7845-2

Search

Navigation